Pharmacy-Based Contraception Care During COVID-19

Online Home Study CoursePharmacy Contraception Care During COVID-19

About this Course

COVID-19 requires modifications to pharmacy operations and clinical services.

The goal of this educational program is to increase participant knowledge and comfort with providing contraception care, including prescribing hormonal contraception, in community pharmacy practice settings during the COVID-19 public health emergency.

Note: There is no CPE credit available for this course.


Join our email list to be notified of other live and home study programs.

Target Audience


Registration & Course Fee

This activity has been supported through an education grant from Exeltis, Inc.

  • Pharmacists, no CPE credit $10
  • Pharmacy students/others $10
Educational Methods

Lecture presentation with interactive activities.

Learning Objectives

Upon completing this course, the participant will be able to:

  • Discuss the impact of COVID-19 on access to reproductive health services.
  • Compare pharmacist contraception prescribing protocols with national guidelines for contraception care during COVID-19.
  • Determine which contraceptive methods can be safely provided using no-touch or telehealth visits.
  • Adapt existing protocols for contraception prescribing during COVID-19 to telehealth-based models.

Sally Rafie, PharmD, BCPS, APh, NCMP, FCCP

  • Pharmacist Specialist, UC San Diego Health
  • Assistant Clinical Professor, UCSD Skaggs School of Pharmacy & Pharmaceutical Sciences (w/s)
  • Founder and Advanced Practice Pharmacist, The Pharmacists Clinic
  • Founder, Birth Control Pharmacist

Jennifer Karlin, MD, PhD

  • Assistant Professor and Associate Director, Predoctoral Education Program, Department of Family & Community Medicine, UC Davis

Sonya Frausto, PharmD

Program Planning Committee

Jennefer Russo, MD, MPH

  • Vice Chair of Clinical Affairs, Department of Obstetrics and Gynecology, Harbor-UCLA
  • Associate Professor, UC Irvine School of Medicine
Faculty and Program Planning Committee Disclosures

Sally Rafie, PharmD serves as a Clinical Advisory Board Member for Afaxys, Inc and Speaker for Therapeutics MD. All other individuals involved in the development of this material declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria.

Completing the Course

After registration for this activity, you will receive an email with the course login. Retain this email for access to the course.


Note:  Registration fees are non-refundable.

To schedule a live web-based training session, contact us.